相关实验视频

Updated: Jul 2, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

9.8K

雷曼尼奥西德A在体外抑制CYP3A4,2C9和2D6的活性

Congrong Wang1, Naixiang Zhou2, Mingcui Li3

  • 1Department of Pharmacy Center, Shandong Public Health Clinical Center, Jinan, China.

Xenobiotica; the fate of foreign compounds in biological systems
|February 22, 2024
PubMed
概括

雷曼尼奥西德A抑制主要的CYP450酶,包括CYP3A4,CYP2C9和CYP2D6. 这种抑制表明潜在的药物相互作用与这些酶代谢的药物.

关键词:
在CYP450s中.雷赫曼尼奥西德是一个竞争性抑制是一种竞争性的抑制.非竞争性抑制是一种非竞争性抑制.

更多相关视频

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.2K
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

12.7K

相关概念视频

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K